Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
TBXA2R-ERM Signaling Drives Motility and Metastasis in TNBC
2026-07-13
A recent study identifies the thromboxane A2 receptor (TBXA2R) as a direct activator of ERM proteins, elucidating its role in promoting cell motility, invasion, and metastatic colonization in triple-negative breast cancer (TNBC). These findings advance the mechanistic understanding of GPCR-mediated cytoskeletal regulation and highlight new therapeutic targets for metastasis intervention.
-
Atrial Natriuretic Peptide (ANP), rat: Unraveling Neurocardi
2026-07-13
Discover how Atrial Natriuretic Peptide (ANP) advances research into neurocardiovascular regulation, bridging vascular, metabolic, and neuroimmune mechanisms. This article offers a uniquely integrative analysis of ANP peptide hormone applications in rat models, with actionable insights for cardiovascular disease research.
-
Bradford Protein Assay Kit: Rapid, Sensitive Protein Quantif
2026-07-12
The Bradford Protein Assay Kit delivers rapid, accurate protein concentration measurement for research workflows, especially where speed and sample conservation are priorities. It is best suited for biochemical protein assays in enzyme studies, protein purification, and molecular biology, but users should avoid samples containing known interfering substances or applications demanding absolute protein purity.
-
DAMGO: Precision µ-Opioid Receptor Agonist for Pain Research
2026-07-10
DAMGO stands out as a highly selective µ-opioid receptor agonist, enabling researchers to dissect opioid receptor signaling and pain mechanisms with unmatched specificity. This guide delivers actionable protocols, advanced use cases, and troubleshooting strategies to advance chronic pain and opioid pharmacology research using DAMGO from APExBIO.
-
D-N-Acetylgalactosamine: Technical Parameters for Brain Anal
2026-07-09
D-N-Acetylgalactosamine is designed for precise investigations of glycoprotein constituents in neurological research, particularly brain heteropolysaccharides analysis and glycosylation pathway workflows. It should not be used in protocols requiring ethanol solubility or long-term storage of prepared solutions.
-
Cy5 NHS ester(Et): Technical Guidance for Biomolecule Labeli
2026-07-09
Cy5 NHS ester(Et) enables precise, water-soluble fluorescent labeling of amino groups in proteins and other biomolecules, supporting immunofluorescence, flow cytometry, and fluorescence microscopy. It is not recommended for ethanol-based workflows or long-term storage of labeling solutions, making it best suited for immediate-use, high-fidelity applications.
-
Ibrexafungerp (SKU C8697): Reliable Antifungal Solutions in
2026-07-08
This article delivers evidence-based guidance for researchers and technicians using Ibrexafungerp (SKU C8697) in cell viability and antifungal susceptibility workflows. Drawing on robust in vitro and clinical data, it addresses practical questions on protocol optimization, data interpretation, and product reliability, highlighting how Ibrexafungerp’s unique properties ensure reproducible and sensitive results.
-
PD 173074: Beyond Cancer—New Frontiers in FGFR1 Inhibition
2026-07-08
Explore the advanced roles of PD 173074 in dissecting FGFR1-driven pathways, from adipogenesis to angiogenesis. This in-depth review highlights unique mechanisms and experimental protocols, distinguishing PD 173074’s applications beyond conventional cancer research.
-
Clasto-Lactacystin β-lactone: Precision Proteasome Inhibitor
2026-07-07
Clasto-Lactacystin β-lactone unlocks highly specific, irreversible proteasome inhibition for dissecting cellular protein degradation. Its potency, cell-permeability, and robust workflow compatibility empower advanced studies in cancer, neurodegeneration, and viral immunity research.
-
Decoding Mitochondrial Dysfunction: TMRE’s Role in Translati
2026-07-07
Explore how Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU: C8197) empowers rigorous, mechanism-driven research on mitochondrial membrane potential and dysfunction. This article integrates pivotal mechanistic studies of ROS generation and apoptosis with strategic guidance for translational researchers, contextualizing TMRE’s application in advanced live-cell assays and future precision medicine.
-
EZ Cap™ EPO mRNA (ψUTP): Stability and Neurorepair Benchmark
2026-07-06
EZ Cap™ EPO mRNA (ψUTP) is a high-purity, Cap 1-capped human erythropoietin mRNA engineered for robust translation and superior stability. The product leverages pseudouridine modification and enzymatic capping to enhance protein expression and minimize immune activation. This dossier details mechanistic, benchmarking, and workflow evidence supporting its use in neurorepair and erythropoiesis research.
-
Moesin as a Diagnostic Biomarker of Endothelial Injury in Se
2026-07-06
The reference study identifies moesin (MSN) as a novel and quantifiable biomarker of endothelial injury in sepsis, demonstrating its correlation with disease severity and key inflammatory pathways. These findings highlight MSN’s potential for early diagnosis and severity assessment in clinical and experimental sepsis models.
-
Rucaparib (AG-014699): Protocol Optimization in DNA Damage R
2026-07-05
Rucaparib (AG-014699) stands out in DNA damage response research, enabling precision radiosensitization and mechanistic insight in cancer models with DNA repair vulnerabilities. Discover best-practice workflows, troubleshooting tips, and the latest findings on apoptosis and transcriptional interplay to elevate your experimental outcomes.
-
DRP1 Activation Drives Mitochondrial Fission and Glycolysis
2026-07-04
This study demonstrates that hyperoxia-induced DRP1 activation leads to mitochondrial fission and glycolytic reprogramming in alveolar type II (ATII) cells, contributing to the pathogenesis of bronchopulmonary dysplasia (BPD). The findings identify DRP1 as a potential therapeutic target and clarify the mechanistic links between mitochondrial dynamics and metabolic alterations in neonatal lung injury.
-
Nitrocefin in β-Lactamase Assays: Protocols, Applications, a
2026-07-03
Nitrocefin, a gold-standard chromogenic cephalosporin substrate, enables rapid and precise colorimetric detection of β-lactamase activity, streamlining antibiotic resistance research and inhibitor screening. This article distills cutting-edge experimental workflows and troubleshooting strategies, translating recent pathogen research and advanced protocols into actionable guidance for modern microbiology labs.